Last reviewed · How we verify
NCT06238154
Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds
Phase 4 trial testing Flurbiprofen in Oral Soft Tissue Conditions in 40 participants. Completed in 20 January 2024.
12 January 2024
Quick facts
| Lead sponsor | Yuzuncu Yil University |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 26 October 2023 |
| Primary completion | 12 January 2024 |
| Estimated completion | 20 January 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Flurbiprofen (flurbiprofen) — full drug profile →
Conditions studied
- Oral Soft Tissue Conditions — all drugs for Oral Soft Tissue Conditions →
- Drug Effect — all drugs for Drug Effect →
- Drug Use — all drugs for Drug Use →
Sponsor
Yuzuncu Yil University
Who can join
Adults 40 to 65, any sex, with Oral Soft Tissue Conditions or Drug Effect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The amount of active ingredient in tablet form of flurbiprofen is higher than that in the oral spray form. Therefore, based on the hypothesis that the side effects that may occur depending on the dose can be reduced, this clinical study investigated whether tablet and spray form flurbiprofen would have similar effects on postoperative pain in primarily closed soft tissue wounds in the oral region.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of the analgesic efficacy of spray and tablet flurbiprofen for pain after soft tissue surgery.
Eroglu CN, Yuksek MN, Elasan S, Mizrak YR, et al · · 2024 · PMID 39536200 · DOI 10.1590/1807-3107bor-2024.vol38.0108
Verify or expand the search:
- PubMed search for NCT06238154
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Flurbiprofen
Trials testing the same drug.
- NCT07223671 — Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy · Phase 1 · completed
- NCT07235748 — Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvas · Phase 1 · completed
- NCT05932277 — A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants · Phase 1 · completed
- NCT05852769 — A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants · Phase 1 · completed
- NCT05981365 — Voxelotor CYP and Transporter Cocktail Interaction Study · Phase 1 · completed
Other recruiting trials for Oral Soft Tissue Conditions
Currently open trials in the same condition.
- NCT06052501 — 3D Evaluation of the Lip Support in a Full-arch Implant-supported Rehabilitations · recruiting
- NCT06029322 — A Comparative Clinical Study Between a Collagen Matrix and Collagen Membrane as Wound Protection During Ridge Preservati · NA · active not recruiting
- NCT06454084 — Investigation of Endothelium-dependent Vasodilation in Human Gingiva · NA · active not recruiting
Other Yuzuncu Yil University trials
Trials by the same sponsor.
- NCT07525297 — Mulligan's Mobilization in Rotator Cuff Pathology · NA · not yet recruiting
- NCT07523399 — Joint Health, Balance and Quality of Life in Adults With Hemophilia A · recruiting
- NCT07416877 — The Effects of Dual-Task Exercises on Parameters After Total Knee Arthroplasty · NA · not yet recruiting
- NCT07243925 — Effect of Family Involvement Intervention on Anxiety, Independence, and Psychological Resilience in CABG Surgery Patient · NA · active not recruiting
- NCT07339410 — Physiotherapy to Improve Balance and Walking Capacity in Hemophilia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06238154 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yuzuncu Yil University
- Last refreshed: 26 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06238154.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing